Cargando…
How to promote the accessibility of technology in the era of hESC patents—A comparative analysis of the systems of the US and China
We have entered the era of human embryonic stem cell (hESC) patents and the focus of discussion has shifted to how to rebalance interests. A potential way is to limit hESC patents and seek more effective utilization forms, such as ethical limitation, compulsory licensing, antimonopoly law regulation...
Autores principales: | Zhang, Wei, Chen, Jiajv, Li, Wei, Zhang, Hanyang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10656298/ https://www.ncbi.nlm.nih.gov/pubmed/37738968 http://dx.doi.org/10.1016/j.stemcr.2023.08.013 |
Ejemplares similares
-
hESC-derived immune suppressive dendritic cells induce immune tolerance of parental hESC-derived allografts
por: Todorova, Dilyana, et al.
Publicado: (2020) -
Rethink the patentability of human embryonic stem cell research findings: Relaxation based on benefit weighing
por: Chen, Jiajv, et al.
Publicado: (2021) -
Genome editing HLA alleles for a pilot immunocompatible hESC line in a Chinese hESC bank for cell therapies
por: Ji, Tian‐Tian, et al.
Publicado: (2023) -
Quantification of the morphological characteristics of hESC colonies
por: Orozco-Fuentes, Sirio, et al.
Publicado: (2019) -
hESC Expansion and Stemness Are Independent of Connexin Forty-Three-Mediated Intercellular Communication between hESCs and hASC Feeder Cells
por: Kim, Jin-Su, et al.
Publicado: (2013)